Literature DB >> 26157118

Insights into Chronic Wasting Disease and Bovine Spongiform Encephalopathy Species Barriers by Use of Real-Time Conversion.

Kristen A Davenport1, Davin M Henderson1, Jifeng Bian1, Glenn C Telling1, Candace K Mathiason1, Edward A Hoover2.   

Abstract

UNLABELLED: The propensity for transspecies prion transmission is related to the structural characteristics of the enciphering and new host PrP, although the exact mechanism remains incompletely understood. The effects of variability in prion protein on cross-species prion transmission have been studied with animal bioassays, but the influence of prion protein structure versus that of host cofactors (e.g., cellular constituents, trafficking, and innate immune interactions) remains difficult to dissect. To isolate the effects of protein-protein interactions on transspecies conversion, we used recombinant PrP(C) and real-time quaking-induced conversion (RT-QuIC) and compared chronic wasting disease (CWD) and classical bovine spongiform encephalopathy (cBSE) prions. To assess the impact of transmission to a new species, we studied feline CWD (fCWD) and feline BSE (i.e., feline spongiform encephalopathy [FSE]). We cross-seeded fCWD and FSE into each species' full-length, recombinant PrP(C) and measured the time required for conversion to the amyloid (PrP(Res)) form, which we describe here as the rate of amyloid conversion. These studies revealed the following: (i) CWD and BSE seeded their homologous species' PrP best; (ii) fCWD was a more efficient seed for feline rPrP than for white-tailed deer rPrP; (iii) conversely, FSE more efficiently converted bovine than feline rPrP; (iv) and CWD, fCWD, BSE, and FSE all converted human rPrP, although not as efficiently as homologous sCJD prions. These results suggest that (i) at the level of protein-protein interactions, CWD adapts to a new species more readily than does BSE and (ii) the barrier preventing transmission of CWD to humans may be less robust than estimated. IMPORTANCE: We demonstrate that bovine spongiform encephalopathy prions maintain their transspecies conversion characteristics upon passage to cats but that chronic wasting disease prions adapt to the cat and are distinguishable from the original prion. Additionally, we showed that chronic wasting disease prions are effective at seeding the conversion of normal human prion protein to an amyloid conformation, perhaps the first step in crossing the species barrier.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26157118      PMCID: PMC4542379          DOI: 10.1128/JVI.01439-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  First case of feline spongiform encephalopathy in a captive cheetah born in France: PrP(sc) analysis in various tissues revealed unexpected targeting of kidney and adrenal gland.

Authors:  Stephane Lezmi; Anna Bencsik; Eoin Monks; Thierry Petit; Thierry Baron
Journal:  Histochem Cell Biol       Date:  2003-05-01       Impact factor: 4.304

2.  BSE transmission to macaques.

Authors:  C I Lasmézas; J P Deslys; R Demaimay; K T Adjou; F Lamoury; D Dormont; O Robain; J Ironside; J J Hauw
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

3.  Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.

Authors:  G J Raymond; J Hope; D A Kocisko; S A Priola; L D Raymond; A Bossers; J Ironside; R G Will; S G Chen; R B Petersen; P Gambetti; R Rubenstein; M A Smits; P T Lansbury; B Caughey
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease.

Authors:  G J Raymond; A Bossers; L D Raymond; K I O'Rourke; L E McHolland; P K Bryant; M W Miller; E S Williams; M Smits; B Caughey
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Human prion protein sequence elements impede cross-species chronic wasting disease transmission.

Authors:  Timothy D Kurt; Lin Jiang; Natalia Fernández-Borges; Cyrus Bett; Jun Liu; Tom Yang; Terry R Spraker; Joaquín Castilla; David Eisenberg; Qingzhong Kong; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

6.  Naturally occurring scrapie-like spongiform encephalopathy in five domestic cats.

Authors:  J M Wyatt; G R Pearson; T N Smerdon; T J Gruffydd-Jones; G A Wells; J W Wilesmith
Journal:  Vet Rec       Date:  1991-09-14       Impact factor: 2.695

7.  Molecular evolution of the mammalian prion protein.

Authors:  Teun van Rheede; Marcel M W Smolenaars; Ole Madsen; Wilfried W de Jong
Journal:  Mol Biol Evol       Date:  2003-01       Impact factor: 16.240

8.  Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles.

Authors:  J K Kirkwood; A A Cunningham
Journal:  Vet Rec       Date:  1994-09-24       Impact factor: 2.695

9.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

Review 10.  Other animal prion diseases.

Authors:  Christina J Sigurdson; Michael W Miller
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

View more
  23 in total

Review 1.  Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

2.  Design, implementation, and interpretation of amplification studies for prion detection.

Authors:  Nicholas J Haley; Jürgen A Richt; Kristen A Davenport; Davin M Henderson; Edward A Hoover; Matteo Manca; Byron Caughey; Douglas Marthaler; Jason Bartz; Sabine Gilch
Journal:  Prion       Date:  2018-03-09       Impact factor: 3.931

3.  Pathways of Prion Spread during Early Chronic Wasting Disease in Deer.

Authors:  Clare E Hoover; Kristen A Davenport; Davin M Henderson; Nathaniel D Denkers; Candace K Mathiason; Claudio Soto; Mark D Zabel; Edward A Hoover
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 4.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

5.  Assessment of Chronic Wasting Disease Prion Shedding in Deer Saliva with Occupancy Modeling.

Authors:  Kristen A Davenport; Brittany A Mosher; Brian M Brost; Davin M Henderson; Nathaniel D Denkers; Amy V Nalls; Erin McNulty; Candace K Mathiason; Edward A Hoover
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

6.  Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.

Authors:  Kristen A Davenport; Davin M Henderson; Candace K Mathiason; Edward A Hoover
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  Estimating chronic wasting disease susceptibility in cervids using real-time quaking-induced conversion.

Authors:  Nicholas J Haley; Rachel Rielinger; Kristen A Davenport; Katherine O'Rourke; Gordon Mitchell; Jürgen A Richt
Journal:  J Gen Virol       Date:  2017-10-23       Impact factor: 3.891

Review 8.  Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids.

Authors:  Nicholas J Haley; Jürgen A Richt
Journal:  Pathogens       Date:  2017-08-05

9.  Prion protein gene sequence and chronic wasting disease susceptibility in white-tailed deer (Odocoileus virginianus).

Authors:  Adam L Brandt; Amy C Kelly; Michelle L Green; Paul Shelton; Jan Novakofski; Nohra E Mateus-Pinilla
Journal:  Prion       Date:  2015       Impact factor: 3.931

10.  Early and Non-Invasive Detection of Chronic Wasting Disease Prions in Elk Feces by Real-Time Quaking Induced Conversion.

Authors:  Yo Ching Cheng; Samia Hannaoui; Theodore R John; Sandor Dudas; Stefanie Czub; Sabine Gilch
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.